BNP ASSAY DEVELOPMENT, MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • March 16th, 2006 • Biosite Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 16th, 2006 Company Industry JurisdictionTHIS BNP ASSAY DEVELOPMENT, MANUFACTURE AND SUPPLY AGREEMENT (this “Agreement”) effective as of June 24, 2003 (the “Effective Date”), is entered into by and between BIOSITE INCORPORATED, a Delaware corporation (“Biosite”), having a place of business at 11030 Roselle Street, Suite D, San Diego, California 92121, and BECKMAN COULTER, INC., a Delaware corporation (“Beckman”), having a place of business at 4300 N. Harbor Boulevard, Fullerton, California 92834-3100.
DISTRIBUTION AGREEMENTDistribution Agreement • March 16th, 2006 • Biosite Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 16th, 2006 Company Industry JurisdictionTHIS DISTRIBUTION AGREEMENT (this “Agreement”) effective as of January 1, 2006 (the “Effective Date”), is entered into between BIOSITE INCORPORATED, a corporation under the laws of the State of Delaware (“Biosite”), having a place of business at 9975 Summers Ridge Road, San Diego, California 92121, and FISHER SCIENTIFIC COMPANY L.L.C., a Delaware Limited Liability Company represented by its FISHER HEALTHCARE division, (“FHC”), having a place of business at 9999 Veterans Memorial Drive, Houston, Texas 77038.
SEMI-EXCLUSIVE BNP DIAGNOSTIC LICENSE AGREEMENT between BIOSITE DIAGNOSTICS INCORPORATED and SCIOS INC.Diagnostic License Agreement • March 16th, 2006 • Biosite Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 16th, 2006 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”) is made effective the 30th day of December, 1996 (the “Effective Date”), by and between BIOSITE DIAGNOSTICS INCORPORATED, a corporation organized under the laws of Delaware with its principal place of business at 11030 Roselle Street, San Diego, California 92121 (“Biosite”), and SCIOS INC., a corporation organized under the laws of the State of Delaware with a principal place of business at 2450 Bayshore Parkway, Mountain View, California 94043 (“Scios”).
AMENDMENT NO. 2 TO SEMI-EXCLUSIVE BNP DIAGNOSTIC LICENSE AGREEMENTDiagnostic License Agreement • March 16th, 2006 • Biosite Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 16th, 2006 Company Industry JurisdictionTHIS AMENDMENT NO. 2 TO SEMI-EXCLUSIVE BNP DIAGNOSTIC LICENSE AGREEMENT (this “Amendment”), dated as of August 30, 2002 (the “Amendment Date”), is entered into between BIOSITE INCORPORATED, a Delaware corporation (“Biosite”), having a place of business located at 11030 Roselle Street, Suite D, San Diego, California 92121, and SCIOS INC., a Delaware corporation (“Scios”), having a place of business at 2450 Bay Shore Parkway, Mountain View, California 94043.
FIRST AMENDMENT TO SEMI-EXCLUSIVE BNP DIAGNOSTIC AGREEMENT between BIOSITE DIAGNOSTICS INCORPORATED and SCIOS INC.Diagnostic Agreement • March 16th, 2006 • Biosite Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 16th, 2006 Company IndustryTHIS FIRST AMENDMENT TO SEMI-EXCLUSIVE BNP DIAGNOSTIC AGREEMENT is entered into as of August 1, 1997 between BIOSITE DIAGNOSTICS INCORPORATED, a corporation organized under the laws of Delaware with its principal place of business at 11030 Roselle Street, San Diego, California 92121 (“Biosite”), and SCIOS INC., a corporation organized under the laws of Delaware with a principal place of business at 2450 Bayshore Parkway, Mountain View, California 94043 (“Scios”);